Onderneming Heron Therapeutics Inc OTC Bulletin Board
Aandelen
APPAD
US4277461020
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutic Innovations
100,0
%
| 108 | 100,0 % | 127 | 100,0 % | +17,99% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 108 | 100,0 % | 127 | 100,0 % | +17,99% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21-02-23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16-06-23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-11-18 |
Chief Tech/Sci/R&D Officer | 65 | 30-03-12 | |
John C. Arthur
PRN | Corporate Officer/Principal | 58 | 01-01-17 |
Sean T. Ristine
HRO | Human Resources Officer | 54 | 01-08-14 |
William Forbes
PRN | Corporate Officer/Principal | 62 | 06-06-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21-02-23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20-09-21 |
Craig Johnson
BRD | Director/Board Member | 62 | 13-01-14 |
Christian Waage
BRD | Director/Board Member | 57 | 22-06-16 |
Adam Morgan
CHM | Chairman | 45 | 21-02-23 |
Director/Board Member | 49 | 20-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 150 653 158 | 149 597 060 ( 99,30 %) | 0 | 99,30 % |
Bedrijfsgegevens
Heron Therapeutics, Inc.
4242 Campus Point Court Suite 200
92121, San Diego
+858 251 4400
http://www.herontx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,74% | 47,54 mld. | |
-0,47% | 41,96 mld. | |
+47,81% | 41,55 mld. | |
+25,40% | 30,36 mld. | |
+17,96% | 27,61 mld. | |
-4,47% | 28,7 mld. | |
+50,73% | 14,7 mld. | |
+42,56% | 13,51 mld. | |
+1,46% | 12,34 mld. |